LA JOLLA PHARMACEUTICAL CO Operating Lease, Payments
LA JOLLA PHARMACEUTICAL CO reported Operating Lease, Payments of $45.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-08-15
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for the quarter ending 2022-06-30 was $45.00K, a 55.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for the quarter ending 2022-03-31 was $45.00K, a 10.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for the quarter ending 2021-12-31 was $100.00K, a 50.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for the quarter ending 2021-09-30 was $33.00K, a 95.88% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for fiscal 2021 was $200.00K, a 93.33% decline from fiscal 2020.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for fiscal 2020 was $3.00M, a 21.05% decline from fiscal 2019.
- LA JOLLA PHARMACEUTICAL CO operating lease, payments for fiscal 2019 was $3.80M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | $45.00K 10-Q · filed 2022-08-15 | $100.00K 10-Q · filed 2022-08-15 | $190.00K derived: sum of 3 quarters · filed 2022-08-15 | $223.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2022-03-31 | $45.00K 10-Q · filed 2022-05-16 | $145.00K derived: sum of 2 quarters · filed 2022-05-16 | $178.00K derived: sum of 3 quarters · filed 2022-05-16 | $278.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $133.00K derived: sum of 2 quarters · filed 2022-03-09 | $233.00K derived: sum of 3 quarters · filed 2022-08-15 | $200.00K 10-K · filed 2022-03-09 | |
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-04 | $133.00K derived: sum of 2 quarters · filed 2022-08-15 | $100.00K 10-Q · filed 2021-11-04 | $383.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-15 | $51.00K 10-Q · filed 2021-08-05 | $100.00K 10-Q · filed 2022-08-15 | $350.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.15M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $50.00K 10-Q · filed 2022-05-16 | $250.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.05M derived: sum of 3 quarters · filed 2022-05-16 | $2.05M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $1.00M derived: sum of 2 quarters · filed 2022-03-09 | $2.00M derived: sum of 3 quarters · filed 2022-03-09 | $3.00M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $800.00K 10-Q · filed 2021-11-04 | $1.80M derived: sum of 2 quarters · filed 2021-11-04 | $2.80M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-05 | $1.90M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $1.60M 10-Q · filed 2021-05-07 | ||||
| 2019-12-31 | $3.80M 10-K · filed 2021-03-08 |